Unknown NA INTERVENTIONAL 7-arm NCT05939219

Consistency, Immunogenicity, and Safety of Three Batches of 15-valent Pneumococcal Conjugate Vaccine

Clinical Study on the Consistency of 15-valent Pneumococcal Conjugate Vaccine in Three Batches of 3-month-old Population and the Immunogenicity and Safety of Vaccination in 7-5-year-old Population

Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Conditions Healthy Volunteers

Interventions 13 valent pneumococcal polysaccharide conjugate vaccine 15-valent pneumococcal conjugate vaccine 202210001 15-valent pneumococcal conjugate vaccineY202210002 15-valent pneumococcal conjugate vaccineY202210003 15-valent pneumococcal conjugate vaccineY202210004

Updated 4 times since 2023 Last updated: Jul 11, 2023 Started: Jul 1, 2023 Primary completion: Jan 31, 2025 Completion: Jun 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05939219, this NA trial focuses on Healthy Volunteers and remains ongoing. Sponsored by Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Aug 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Aug 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Aug 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Jul 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Data source: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shijiangzhuang, China